| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |